Lilly Zhang
Baylor University Medical Center(US)Takeda (United States)(US)
Publications by Year
Research Areas
Microtubule and mitosis dynamics, Cancer-related Molecular Pathways, Organ and Tissue Transplantation Research, Cancer, Hypoxia, and Metabolism, Vascular Tumors and Angiosarcomas
Most-Cited Works
- → TAK-960, a Novel, Orally Available, Selective Inhibitor of Polo-Like Kinase 1, Shows Broad-spectrum Preclinical Antitumor Activity in Multiple Dosing Regimens(2011)77 cited
- → Twelve Live Births After Uterus Transplantation in the Dallas UtErus Transplant Study(2021)69 cited
- → Discovery of TAK-960: An orally available small molecule inhibitor of polo-like kinase 1 (PLK1)(2013)48 cited
- → Biological Characterization of TAK-901, an Investigational, Novel, Multitargeted Aurora B Kinase Inhibitor(2013)44 cited
- → Neonatal Outcomes after Uterus Transplantation: Dallas Uterus Transplant Study(2021)32 cited
- → Clinical pregnancy rates and experience with in vitro fertilization after uterus transplantation: Dallas Uterus Transplant Study(2021)26 cited
- → Structure-based design and SAR development of 5,6-dihydroimidazolo[1,5-f]pteridine derivatives as novel Polo-like kinase-1 inhibitors(2016)18 cited
- → Design and synthesis of orally available MEK inhibitors with potent in vivo antitumor efficacy(2012)18 cited
- → Anesthesiology Effect of Intravenous Sedation on the Outcome of Transvaginal Oocyte Retrieval: A Comparative Study of Propofol- and Methohexital-Based Techniques(1997)7 cited
- → AN EVALUATION OF KERNEL EQUATING: PARALLEL EQUATING WITH CLASSICAL METHODS IN THE SAT SUBJECT TESTS™ PROGRAM(2009)4 cited